DCZ3301

N/A

Report date: 2023/03/10 15:30:24
NME

Base Information

Drug NameDCZ3301
Drug Alias NameDCZ-3301DCZ3301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase Lyn inhibitors
TargetsTyrosine-protein kinase Lyn
Therapy Area/IndicationsLymphoma, Large B-Cell, Diffuse
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Oriental Hospital
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Oriental Hospital
Inactive CompaniesN/A
Active IndicationsLymphoma, Large B-Cell, Diffuse
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A